Helping lab professionals GoMolecular.

Key Contributors

   Thank you to our key opinion leaders for sharing their experiences and insights
   with GoMolecular!

 

 


Rodney Climaco Arcenas, Ph.D., D(ABMM)
Kathleen G. Beavis, M.D. 
Janet Robinson
Joan T. Gordon, M.T. (ASCP)
Giovanni Guidotti
Frederick L. Kiechle, M.D., Ph.D.
Charles Kiyaga
Nickolas G. Mitilenes, B.A.
Preeti Pancholi, Ph.D., D(ABMM)
Charles Root, Ph.D.
Gregory Storch, M.D.
Yun F. Wang, M.D., Ph.D.
Kejian Zhang M.D., M.B.A
Yanming Zhang, M.D.


 




Rodney Climaco Arcenas, Ph.D., D(ABMM)


Dr. Arcenas is the lab director at Memorial Healthcare System in Hollywood, Fla., working for Pathology Consultants of South Broward, LLP. He is a clinical scientist in microbiology, immunology, and molecular applications. Arcenas is a member of the American Society for Microbiology, the Infectious Disease Society of America and the Association of Molecular Pathology. Education: B.S. in microbiology, University of Florida; M.S. in medical microbiology and immunology, University of South Florida College of Medicine; M.D. of philosophy in medical microbiology and immunology, University of South Florida Medical College.


Kathleen G. Beavis, M.D.


Kathleen G. Beavis, M.D., is currently the Chair of the Divisions of Microbiology and Virology at Stroger Hospital of Cook County in Chicago (formerly Cook County Hospital) and a clinical associate professor in the Department of Pathology at the UIC School of Medicine.  Dr. Beavis was the chair of the Microbiology Resource Committee for the College of American Pathologists and is a member of the Council of Scientific Affairs and the Technology Assessment Committee for the College.  She is a recipient of the 2009 CAP Lifetime Achievement Award. Dr. Beavis has also served as member, chair and consultant of the Advisory Panel on Microbiology Devices, and she is a member of the Microbiology Test Committee of the American Board of Pathology.  

Dr. Beavis’ main professional interests have been in the implementation of clinically relevant, cost-effective microbiology.  She has used automation to perform testing around the clock as needed and to free up highly skilled technologists for other work.

Dr. Beavis earned an AB in philosophy from Harvard-Radcliffe College, in Cambridge, Mass. She then completed a Rotary International graduate fellowship at Eberhard Karls Universität in Tübingen, Germany, before attending Bryn Mawr College in Pennsylvania for a post-baccalaureate, pre-medical program. Dr. Beavis completed her medical degree at the University of Pennsylvania School of Medicine in Philadelphia. In addition, she is certified by the American Board of Pathology in Clinical Pathology.



Janet Robinson


Janet Robinson is the Director of Research, Asia Pacific Region, and the Global Director of Laboratory Sciences for FHI 360 based in Durham, N.C. Robinson is a clinical, regulatory, laboratory, and quality specialist with more than 25 years of experience in medical laboratory diagnostics and clinical trials. For the past 10 years she has provided leadership, implementation, technical assistance, capacity building and training to clinical research and program professionals and institutions in developing countries, particularly in west and sub-Saharan Africa and Southeast Asia. Robinson is a certified clinical pathologist (University of London, England), and is a Fellow of the Institute of Biomedical and Laboratory Sciences (UK). She is an invited member of several international laboratory working groups, including the Clinton Foundation and WHO in Southeast Asia. She is also a member of the U.S. FDA Advisory Committee for Clinical Chemistry, and of the American Society of Microbiology.



Joan T. Gordon, M.T. (ASCP)


Joan Gordon, President of Maine Molecular Quality Controls, Inc. (MMQCI) has more than 25 years of experience in the diagnostic testing field, first working in Clinical Chemistry and then Molecular Pathology at Maine Medical Center in Portland, Maine. For the past 11 years, Gordon has focused solely on the development of nucleic acid controls as co-owner and President of Maine Molecular Quality Controls, Inc. (MMQCI). MMQCI provides the biomedical industry with innovative, high-quality control products for molecular diagnostics. Gordon is an active member in professional organizations, the CDC’s program for Genetic Testing Reference Materials, is a contributor to CLSI guidelines for molecular testing, is a member of the Joint Committee for Traceability in Laboratory Medicine (JCTLM) and serves on the board of the Center for Innovation in Biotechnology in Maine.


Giovanni Guidotti


Dr. Giovanni Guidotti is Coordinator and General Secretary of Drug Resource Enhancement against AIDS and Malnutrition program, or DREAM. In 1990 he began his career in HIV/AIDS research with the Italian National Institute of Health, and earned postdoctoral training and specialization in Internal Medicine at the University of Rome, “La Sapienza.” He then worked in the Hospital Santo Spirito in Rome in home health services. In 2001 Dr. Guidotti partnered with the Italian cooperation in Mozambique through the Community of Sant’Egidio, helping launch a pilot DREAM treatment program for HIV/AIDS. He initiated an Italian National Institute of Health research program for HIV/AIDS in Sub-Saharan Africa in 2003. Dr. Guidotti obtained a PhD in Experimental Molecular Oncology in 2013 from the University of Pisa, Italy. For more than a decade, he has provided strong leadership in establishing treatment centers and molecular biology laboratories in ten African countries, positively impacting the lives of nearly half a million patients.



Frederick L. Kiechle, M.D., Ph.D.

Since July 2006, Dr. Kiechle has served as the Medical Director of Clinical Pathology for the five-hospital (1,792 beds) Memorial Healthcare System in Hollywood, Fla., working for Pathology Consultants of South Broward, LLP. The laboratory system performed 7.9 million tests in 2010. He has published 194 peer-reviewed articles or book chapters and 214 abstracts. He is the author of the best-selling lab management book, The Hitchhiker’s Guide to Efficiency in the Clinical Laboratory, published by the AACC, and co-editor of Molecular Diagnostics. Techniques and Applications for the Clinical Laboratory, 2010, Academic Press. Dr. Keichle lectures nationally and internationally on basic research topics, point-of-care testing, automation, laboratory design, outreach program and molecular diagnostics. Education: B.A. in Chemistry, Evansville College, Evansville, Ind.; Ph.D. in Biochemistry, Indiana University, Bloomington, Ind.; M.D., Indiana University Medical School, Indianapolis, Ind.; Ph.D. Thesis: The Effect of Beta-aminoketone and Related Compounds on Uninfected and T4-infected Escherichia coli B.


Charles Kiyaga

Charles Kiyaga is a biomedical scientist and the national coordinator for the Early Infant Diagnosis (EID) program within the Central Public Health Laboratories (CPHL), Ministry of Health in Uganda. The EID program has been testing HIV-exposed infants since 2007 and has tested over 250,000 babies to date. Kiyaga was instrumental in the consolidation of eight labs into one centralized lab, and the creation of a sample transport network for the EID program.

Kiyaga has earned two bachelor’s degrees: one in Health Systems Approach to HIV Care and Management at the University of Manchester UK; and one in Biomedical Lab Technology at the Makerere University Kampala, Uganda. He earned a master’s of science in Biomedical Lab Technology and Management at the Makerere University Kampala, Uganda. He also holds certificates in medical mycology and medical laboratory technology, and a diploma in medical lab technology.



Nickolas G. Mitilenes, B.A.

Nickolas G. Mitilenes, B.A., is the Vice President and Chief Technology Officer of MedLabs Diagnostics in Cedar Knolls, N.J. His current responsibilities include oversight of all core laboratory operations as well as direct management of Department of Molecular Diagnostics. Mitilenes also serves as a member of the board of directors at MedLabs Diagnostics and is also a founding partner of Horsehill Properties, a healthcare-oriented real estate company. He is a member of numerous associations, including: the American Association of Bioanalysts (AAB), the American Society of Clinical Pathology (ASCP), the American Association for Clinical Chemistry (AACC), and the Association for Molecular Pathology (AMP). Mitilenes earned a Bachelor of Arts (BA) in molecular biology at Colgate University in Hamilton, N.Y. He has extensive training in operations, as well as leadership development.


Preeti Pancholi, Ph.D., D(ABMM)

Dr. Preeti Pancholi is the Director of Clinical Microbiology and Associate Professor of Clinical Pathology at The Ohio State University Medical Center in Columbus, Ohio. Dr. Pancholi is responsible for the daily management of clinical microbiology laboratory offering diagnostic testing in bacteriology, antimicrobial susceptibility testing, mycology, mycobacteriology, parasitology, virology and molecular diagnostics.  Dr. Pancholi earned her Ph.D. at the Postgraduate Institute of Medical Education & Research, Microbiology and Immunology, Chandigarh, India. She completed a post-doctoral training at Rockefeller University in New York, and a clinical microbiology fellowship from Mayo Clinic, Rochester, Minn. Prior to moving to Columbus, she was Associate Director, Clinical Microbiology and Molecular Diagnostics at Columbia-Presybyterian Medical Center in New York.

Dr. Pancholi is a member of the American Society for Microbiology (ASM), and is on the editorial board for the Journal of Clinical Microbiology and the Journal of Clinical Virology. She has contributed as a voting member for drafting guidelines on the CLSI committee for, “Establishing Molecular Testing in Clinical Laboratory Environments Guideline.” Dr. Pancholi has served on the nominating committee for the Association of Molecular Pathology (Infectious Disease Division). She is presently the South Central Association Clinical Microbiology Director for the State of Ohio.

Dr. Pancholi’s primary research interests are the use of molecular and other rapid technologies to improve clinical infectious disease diagnostics and, further, to evaluate the impact of these technologies on patient care. She is actively involved in several research collaborations including methicillin resistant S. aureus, hepatitis C virus, and has received industry and federal funding support for her research.



Charles Root, Ph.D.

Dr. Charles Root is the Founder and President of CodeMap. He has provided laboratory coding and reimbursement information to healthcare providers and manufacturers for more than 18 years. Dr. Root is a member of the Clinical Laboratory Management Association (CLMA), as well as the American Association of Clinical Chemists (AACC) and has served on their Government Relations Committee. He provides frequent input and comments to Centers for Medicare and Medicaid Services (CMS) on laboratory issues and provides input to the American Medical Association’s Pathology Coding Caucus regarding CPT coding for lab services. Dr. Root received his Ph.D. in physical chemistry and nuclear physics from the Catholic University of America, in Washington, D.C., and has taken postgraduate courses in business management and economics from Harvard and Northwestern Universities. Prior to founding CodeMap LLC, Dr. Root worked as a rocket scientist with the U.S. Navy on missile systems and high-energy materials.


Gregory Storch, M.D.

Dr. Storch holds numerous positions in the field of pediatric infectious disease and microbiology at Washington University School of Medicine in St. Louis. His many titles include: Ruth L. Siteman Professor of Pediatrics, Medicine, and Molecular Microbiology; and Director, Divisions of Laboratory Medicine and Infectious Diseases, Department of Pediatrics. Dr. Storch also serves on the Microbiology - Infectious Diseases Liaison Committee at Washington University School of Medicine, and on the Infection Control Committee at St. Louis Children's Hospital. He received his Bachelor of Arts degree from Harvard University, and his medical degree from New York University Medical School.


Yun F. Wang, M.D., Ph.D.

Dr. Yun F. Wang is an Associate Professor of Pathology and Laboratory Medicine at Emory University School of Medicine, and Director of Microbiology, Immunology, and Molecular Diagnostics at Grady Memorial Hospital in Atlanta. Dr. Wang is in charge of the Clinical Microbiology, Immunology and Molecular Diagnostics Laboratory at Grady Memorial Hospital, the largest public hospital in the Southeast. He is responsible for rapid and cost effective laboratory diagnosis of infectious diseases, particularly in HIV, tuberculosis, and sexually transmitted disease. Dr. Wang is a member of a number of professional associations and societies, including the American Society for Microbiology (ASM), the Association for Molecular Pathology (AMP), and Infectious Disease Society of America (IDSA). He is currently the councilor for the Division of Clinical and Molecular Immunology of ASM after serving as division chair last year.  He is the current member of Georgia TB Task Force.  He has been the member for CDC working groups for guidelines, including the recent guidelines for biosafety laboratory competency organized by the CDC and the Association of Public Health Laboratories (APHL). Dr. Wang earned his medical degree at Shanghai Medical College of Fudan University, in Shanghai, China; and his Ph.D. at the Medical College of Ohio in Toledo. He is a journal reviewer for a number of journals and he is an editorial board member for the Journal of Clinical Microbiology and Journal of Clinical Virology.


Kejian Zhang  M.D., M.B.A

Kejian Zhang  M.D., M.B.A, is the Director of the Molecular Genetics Laboratory and an Associate Professor of Pediatrics at the Cincinnati Children’s Hospital Medical Center in Ohio. Dr. Zhang is certified in Clinical Molecular Genetics by the American Board of Medical Genetics, and holds a U.S. patent for Diagnostic Assay for Wiskott-Aldrich Syndrome and Genetically Associated Disorders in 2009. Her main research focus includes molecular defects and molecular diagnosis of primary immunodeficiency diseases; genetic aspects of predictive personalized medicine (pharmacogenetics). Dr. Zhang is a member of many professional organizations, including the American Society of Human Genetics, the American College of Medical Genetics, the American Society of Molecular Pathology, the Public Population Project in Genomics (P3G), the Chinese Association of Medical Genetics, and the International Histiocyte Society. Dr. Zhang earned her medical degree at Tianjin Medical University in Tianjin, China, and her MBA at the University of Cincinnati, College of Business Administration.


Yanming Zhang, M.D.

Yanming Zhang, M.D., is an Associate Professor, Department of Pathology, at Northwestern University Feinberg School of Medicine, and is Medical Director of the Cytogenetics Laboratory at Northwestern Memorial Hospital, Chicago. He is board certified in clinical cytogenetics by the American Board of Medical Genetics (ABMG), and is a member of the American Society of Hematology (ASH), Association of Molecular Pathology (AMP), and the United States & Canadian Academy of Pathology (USCAP). Dr. Zhang also serves as a reviewer for Gene, Chromosome & Cancer, Leukemia, Leukemia and Lymphoma, Cancer Genetics and Cytogenetics, and Journal of Medical Genetics. He is a certified laboratory inspector for the College of American Pathologists (CAP).

Dr. Zhang earned his bachelor’s degree of medicine, and master’s degree of science in medicine at Zhejiang University, School of Medicine, Hangzhou, P. R. China, and his doctor of medicine in Human Genetics at the University of Kiel, Kiel, Germany. He did his postdoctoral research training in the Institute of Human Genetics, University of Kiel, Kiel, Germany, and in the Department of Medicine, Section of Hematology/Oncology, the University of Chicago; and finished a Clinical Cytogenetics Fellowship training, accredited by ABMG, in the Department of Medicine, University of Chicago. Dr. Zhang’s research interests are using genomic microarray techniques to discover and characterize cooperative genomic abnormalities with recurring chromosome translocations in the initiation and transformation to leukemia, and performing molecular genetic studies to clone novel chromosome translocations in cancer. He has published more than 50 peer-reviewed papers, and various reviewing articles of chromosome abnormalities and their mechanisms in leukemia and lymphoma.